Celemics, Inc.

Publications

Celemics’ Publications

MLH1 single‑nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma

Scientific Reports

MLH1 single‑nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma

Kim SS, Eun JW, Choi JH, Woo HG, Cho HJ, Ahn HR, et al. MLH1 single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma. Sci Rep. 2020 Oct 20;10(1):17862.

 

10.1038/s41598-020-74494-y